Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $5.73 -0.21 (-3.54%) Closing price 04:10 PM EasternExtended Trading$5.84 +0.11 (+1.92%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.68Holdings in PILL have an aggregate rating of Moderate Buy based on 229 analyst ratings issued in the past year covering 21 companies (50.0% of the portfolio).PILL Aggregate Price Target$5.73High Prediction$5.73Average Prediction$5.73Low Prediction$5.73Holdings in PILL have an aggregate price target of $5.73 and a range of $5.73 to $5.73 covering 21 companies (50.0% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.75%PFEPfizer$24.46-0.5%4.9618 of 5 stars2.45$28.55 16.7%22Trending News2.74%RPRXRoyalty Pharma$35.59+0.3%4.9715 of 5 stars3.25$48.33 35.8%4News CoveragePositive NewsDividend Announcement2.72%ELANElanco Animal Health$14.78-1.2%1.8068 of 5 stars2.88$16.00 8.3%8Analyst UpgradeAnalyst Revision2.71%VTRSViatris$8.88-4.2%3.2683 of 5 stars1.80$10.40 17.1%5Trending News2.66%MRKMerck & Co., Inc.$79.97-1.9%4.9955 of 5 stars2.43$108.69 35.9%21Positive News2.64%JNJJohnson & Johnson$163.65+0.4%4.7807 of 5 stars2.57$172.87 5.6%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastOptions VolumeAnalyst Revision2.64%AXSMAxsome Therapeutics$111.70-0.5%4.7309 of 5 stars3.06$172.33 54.3%16Analyst Revision2.61%PRGOPerrigo$26.95-0.7%4.6264 of 5 stars2.25$33.00 22.4%4News CoveragePositive News2.60%OGNOrganon & Co.$9.46-1.9%4.8555 of 5 stars2.50$18.00 90.3%6Trending News2.60%JAZZJazz Pharmaceuticals$112.87-1.7%4.8076 of 5 stars2.93$181.71 61.0%14Analyst Forecast2.53%TARSTarsus Pharmaceuticals$43.25+4.5%1.7763 of 5 stars3.00$66.67 54.1%7News CoverageAnalyst RevisionGap Up2.53%LLYEli Lilly and Company$771.78+1.3%4.9798 of 5 stars2.75$1,012.56 31.2%20Trending News2.52%CORTCorcept Therapeutics$70.86-3.1%4.7921 of 5 stars3.00$138.25 95.1%52.50%ZTSZoetis$148.61-0.9%4.9604 of 5 stars2.70$204.63 37.7%10Trending NewsAnalyst DowngradeAnalyst Revision2.47%BMYBristol Myers Squibb$47.40-1.4%4.8944 of 5 stars2.32$57.69 21.7%22Trending NewsAnalyst Revision2.43%PBHPrestige Consumer Healthcare$75.70+0.8%3.9975 of 5 stars2.50$93.33 23.3%6News CoveragePositive NewsAnalyst Revision1.97%HRMYHarmony Biosciences$35.20-3.4%4.801 of 5 stars3.00$51.33 45.8%9Positive News1.73%PCRXPacira BioSciences$21.59-3.1%3.1024 of 5 stars2.33$26.44 22.5%91.65%ANIPANI Pharmaceuticals$66.30-2.6%3.7657 of 5 stars3.00$78.88 19.0%91.55%AMRXAmneal Pharmaceuticals$7.97-3.3%3.2298 of 5 stars3.00$11.60 45.5%5News Coverage1.47%OCULOcular Therapeutix$11.33-0.4%3.9265 of 5 stars3.00$17.33 53.0%6 This page (NYSEARCA:PILL) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PILL Stock Alerts